Cancer biology & medicine

01 14 October 2026

DOI 10.20892/j.issn.2095-3941.2026.0738

Erratum to Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway

Open DOI

Lianmei Zhao, Jie Li, Yueping Liu et al.

02 23 September 2026

DOI 10.20892/j.issn.2095-3941.2026.0336

A bispecific EGFR × HER3 antibody–drug conjugate for later-line recurrent or metastatic nasopharyngeal carcinoma: insights from BL-B01D1-303

Open DOI

Huaqiang Zhou, Jiayi Shen, Jiaqing Liu et al.

03 17 September 2026

DOI 10.20892/j.issn.2095-3941.2026.0311

Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial

Open DOI

Mengjie Li, Caixia Liu, Fengming Ran et al.

Objective: Primary prophylaxis with granulocyte colony-stimulating factor (G-CSF) is recommended for patients receiving chemotherapy with a high risk of febrile neutropenia (FN), but its use remains suboptimal in patients receiving inter...

Read abstract

04 15 September 2026

DOI 10.20892/j.issn.2095-3941.2026.0154

Revisiting the immunosuppressive microenvironment in hepatocellular carcinoma: a functional taxonomy of immune cells and therapeutic targeting

Open DOI

Jiaqian Zhang, Siwen Li, Xianglong Ma et al.

Despite transformative success in other solid tumors, immunotherapy has encountered a formidable barrier in hepatocellular carcinoma (HCC), a profoundly immunosuppressive tumor microenvironment (TME) that is predominantly “cold” and also...

Read abstract

05 8 September 2026

DOI 10.20892/j.issn.2095-3941.2025.0803

Migrasome-propagated ITGβ3-TGFβ1 circuit orchestrates breast cancer brain metastasis by reprogramming the microglial niche

Open DOI

Song Wang, Xinmiao Xian, Guohao Gu et al.

Objective: The dismal prognosis of breast cancer brain metastasis (BCBM) is attributed to a maladapted tumor microenvironment. This study was aimed at deciphering the role of novel intercellular communicators, tumor-derived migrasomes, i...

Read abstract

06 8 September 2026

DOI 10.20892/j.issn.2095-3941.2026.0704

Erratum to From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management

Open DOI

Junnan Xu, Kun Fang, Xiaoxi Li et al.

07 13 August 2026

DOI 10.20892/j.issn.2095-3941.2026.0058

cGAS–STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy

Open DOI

Xinru Zhao, Shuai Meng, Hanzeng Cheng et al.

The cyclic GMP-AMP synthase–stimulator of interferon genes (cGAS–STING) pathway is a central sensor of innate immunity that plays critical roles in recognizing cytosolic DNA and initiating antitumor immune responses. However, this pathwa...

Read abstract

08 8 August 2026

DOI 10.20892/j.issn.2095-3941.2026.0316

Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life

Open DOI

Yingni Zhang, Chunxian Ou, Cheng Xu

09 6 August 2026

DOI 10.20892/j.issn.2095-3941.2025.0851

Global landscape and temporal trends in lifetime risk of colorectal cancer in 185 countries: a population-based study

Open DOI

Li Li, Kexin Sun, Xiang Li et al.

Objective: Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related mortality worldwide. This study was aimed at estimating regional and national variations in lifetime CRC risk worldwide. Me...

Read abstract

10 4 August 2026

DOI 10.20892/j.issn.2095-3941.2026.0129

Anogenital human papillomavirus infection patterns by anatomical site and sexual orientation in Chinese men: a national multi-center study

Open DOI

Shangying Hu, Huan Yang, Jinyu Zhang et al.